Kim Westi Jorgensen

Title: Kim Westi Jorgensen: Innovator in Modified Release Formulations

Introduction

Kim Westi Jorgensen is a notable inventor based in Soborg, Denmark. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of modified release drugs. His work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Jorgensen holds a patent for "Modified release formulations containing (R)-1-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-propyl)-3-piperidinecarboxylic acid." This patent describes modified release formulations with zero-order drug release that are effective in treating disorders related to neurogenic inflammation and non-insulin-dependent diabetes mellitus (NIDDM). His innovative approach involves dispersing the active compound in a polymeric matrix that includes at least one release rate controlling polymer.

Career Highlights

Jorgensen is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at the company allows him to apply his expertise in drug formulation and development, contributing to advancements in patient care.

Collaborations

Throughout his career, Jorgensen has collaborated with several talented professionals, including Tina Meinertz Andersen and Thyge Borup Hjorth. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.

Conclusion

Kim Westi Jorgensen is a distinguished inventor whose work in modified release formulations has the potential to improve treatment options for patients with specific medical conditions. His contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.